These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 31079970

  • 1. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC, Teng HI, Chen HY, Wu CJ, Tsai CT, Hsueh CH, Chen YY, Hau WK, Lu TM.
    Int J Cardiol; 2019 Aug 15; 289():131-137. PubMed ID: 31079970
    [Abstract] [Full Text] [Related]

  • 2. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A.
    Int J Cardiovasc Imaging; 2017 Oct 15; 33(10):1463-1472. PubMed ID: 28444549
    [Abstract] [Full Text] [Related]

  • 3. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L, Mintz GS, Yin D, Yamamoto MH, Chin CY, Matsumura M, Fall K, Kirtane AJ, Parikh MA, Moses JW, Ali ZA, Shlofmitz RA, Maehara A.
    Int J Cardiovasc Imaging; 2017 Aug 15; 33(8):1115-1124. PubMed ID: 28281026
    [Abstract] [Full Text] [Related]

  • 4. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y.
    Catheter Cardiovasc Interv; 2015 Mar 15; 85(4):564-72. PubMed ID: 25158217
    [Abstract] [Full Text] [Related]

  • 5. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ, Shi B, Deng CC, Xu GX, Zhao RZ, Shen CY, Wang ZL, Liu HL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan 24; 46(1):44-49. PubMed ID: 29374937
    [Abstract] [Full Text] [Related]

  • 6. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis.
    Nakamura D, Dohi T, Ishihara T, Kikuchi A, Mori N, Yokoi K, Shiraki T, Mizote I, Mano T, Higuchi Y, Yamada T, Nishino M, Sakata Y.
    EuroIntervention; 2021 Aug 27; 17(6):489-496. PubMed ID: 32985411
    [Abstract] [Full Text] [Related]

  • 7. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A, Prevention of PRESTIGE Investigators.
    JACC Cardiovasc Interv; 2018 Jul 23; 11(14):1340-1350. PubMed ID: 30025727
    [Abstract] [Full Text] [Related]

  • 8. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C, Zhang P, Han B, Li X, Liu Y, Niu D, Shi Y.
    Medicine (Baltimore); 2018 Aug 23; 97(34):e12117. PubMed ID: 30142870
    [Abstract] [Full Text] [Related]

  • 9. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Circ Cardiovasc Interv; 2015 Feb 23; 8(2):e001878. PubMed ID: 25613674
    [Abstract] [Full Text] [Related]

  • 10. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R, Dijkstra J, Räber L, Torii R, Zhang YJ, Karanasos A, Lui S, Crake T, Hamshere S, Garcia-Garcia HM, Tenekecioglu E, Ozkor M, Windecker S, Serruys PW, Regar E, Mathur A, Bourantas CV.
    EuroIntervention; 2018 Feb 02; 13(15):e1831-e1840. PubMed ID: 28606888
    [Abstract] [Full Text] [Related]

  • 11. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H, Loh JP, Pendyala LK, Omar A, Ota H, Minha S, Magalhaes MA, Torguson R, Chen F, Satler LF, Pichard AD, Waksman R.
    Cardiovasc Revasc Med; 2014 Apr 02; 15(3):149-55. PubMed ID: 24767313
    [Abstract] [Full Text] [Related]

  • 12. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
    Kimura S, Sugiyama T, Hishikari K, Nakamura S, Nakagama S, Misawa T, Mizusawa M, Hayasaka K, Yamakami Y, Sagawa Y, Kojima K, Ohtani H, Hikita H, Takahashi A, Isobe M.
    Int J Cardiovasc Imaging; 2016 Oct 02; 32(10):1483-94. PubMed ID: 27423209
    [Abstract] [Full Text] [Related]

  • 13. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.
    Habara M, Terashima M, Nasu K, Kaneda H, Yokota D, Ito T, Kurita T, Teramoto T, Kimura M, Kinoshita Y, Tsuchikane E, Asakura Y, Suzuki T.
    Eur Heart J Cardiovasc Imaging; 2013 Mar 02; 14(3):276-84. PubMed ID: 22945378
    [Abstract] [Full Text] [Related]

  • 14. Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis　- Optical Coherence Tomography Study.
    Nakamura D, Yasumura K, Nakamura H, Matsuhiro Y, Yasumoto K, Tanaka A, Matsunaga-Lee Y, Yano M, Yamato M, Egami Y, Shutta R, Sakata Y, Tanouchi J, Nishino M.
    Circ J; 2019 Jan 25; 83(2):313-319. PubMed ID: 30487370
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ, Shi B, Deng CC, Xu GX, Zhao RZ, Shen CY, Wang ZL, Liu HL.
    Zhonghua Yi Xue Za Zhi; 2017 Jun 20; 97(23):1778-1783. PubMed ID: 28647998
    [Abstract] [Full Text] [Related]

  • 16. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.
    Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A.
    J Interv Cardiol; 2017 Jun 20; 30(3):195-203. PubMed ID: 28295660
    [Abstract] [Full Text] [Related]

  • 17. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
    Kim HO, Jung HW, Lee JH, Kim JS, Hong SJ, Ahn CM, Kim BK, Kim W, Kim SJ, Kim W, Ko YG, Choi D, Hong MK, Jang Y.
    Coron Artery Dis; 2020 Dec 20; 31(8):694-702. PubMed ID: 32976245
    [Abstract] [Full Text] [Related]

  • 18. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T, Fusazaki T, Kimura T, Oikawa H, Sasou S, Ishikawa Y, Goto I, Komuro K, Nakajima S, Koeda Y, Kaneko K, Nishiyama O, Nakamura M, Morino Y.
    Coron Artery Dis; 2015 May 20; 26(3):201-11. PubMed ID: 25714072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of baseline plaque characteristic on the development of neoatherosclerosis in the very late phase after stenting.
    Hoshino M, Yonetsu T, Kanaji Y, Usui E, Yamaguchi M, Hada M, Hamaya R, Kanno Y, Murai T, Lee T, Kakuta T.
    J Cardiol; 2019 Jul 20; 74(1):67-73. PubMed ID: 30733110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.